CELL AND GENE THERAPY INSIGHTS

June 2025 Issue

Volume 11 Issue 5

Cell and Gene Therapy Insights Volume 11 Issue 5
Download PDF

Featuring

Issue Spotlight: Non-viral delivery: manufacturing and analytics
Supply Chain focus: Cryopreservation 2025
Other articles
Webinars

SPOTLIGHT

Non-viral delivery: manufacturing and analytics
Sudhanshu Shekhar
Guest Editor:
Sudhanshu Shekhar, Principal Scientist at Bristol Myers Squibb

Expert Insight

Overcoming mRNA medicine supply hurdles: distributed, continuous and multi-product mRNA manufacturing in a box at high quality and low cost

Overcoming mRNA medicine supply hurdles: distributed, continuous and multi-product mRNA manufacturing in a box at high quality and low cost

Bojan Kopilovic, Mabrouka Maamra, Zoltán Kis
20 June
Read

Review

Targeting T cells in vivo: advances in non-viral gene delivery and clinical applications

Targeting T cells in vivo: advances in non-viral gene delivery and clinical applications

A Nguyen, L Eller, S Carneiro et al.
2 July
Read

Interview

Revolutionizing non-viral gene delivery with silicon-stabilized LNPs

Revolutionizing non-viral gene delivery with silicon-stabilized LNPs

Suzanne Saffie-Siebert
20 May
Read

Supply Chain FOCUS

Cryopreservation 2025

Expert Insight

Navigating non-DEHP legislation while protecting cryopreserved cord blood inventories during regulatory transitions

Navigating non-DEHP legislation while protecting cryopreserved cord blood inventories during regulatory transitions

Ludwig Frontier, Wouter Van't Hof
10 July
Read
Understanding and mitigating risks associated with cryopreservation practices in cell therapy

Understanding and mitigating risks associated with cryopreservation practices in cell therapy

Advitiya Mahajan, Rachel Leon, Allison Hubel
1 July
Read

Viewpoint

Cryopreservation of autologous patient material for onwards manufacture

Cryopreservation of autologous patient material for onwards manufacture

Chris Leonforte
2 June
Read

Journal articles

Innovator Insight

Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Ines Goncalves
7 July
Read
Efficient AAV purification: resin reuse and scalable polish method

Efficient AAV purification: resin reuse and scalable polish method

Duncan Dulac
19 May
Read

Expert Roundtable

A practical guide to fit-for-purpose analytical development in an emerging cell therapy landscape

A practical guide to fit-for-purpose analytical development in an emerging cell therapy landscape

Damian Marshall, Jie Wei, Florian Durst
18 June
Read

FastFacts

Quantitative analysis of AAV capsid heterogeneity with mass photometry

Quantitative analysis of AAV capsid heterogeneity with mass photometry

Maria Jacintha Victoria
14 July
Read

Infographic

How do I ensure my early-stage analytical development is ‘phase-appropriate’? Top 5 tips

How do I ensure my early-stage analytical development is ‘phase-appropriate’? Top 5 tips

3 June
Read

Interview

Exploring the UK’s evolving role in commercializing cell and gene therapies

Exploring the UK’s evolving role in commercializing cell and gene therapies

Matthew Durdy
17 June
Read

Webinars